Biocardiainc Stock Market Capitalization
| BCDA Stock | USD 0.38 0.01 2.70% |
BiocardiaInc fundamentals help investors to digest information that contributes to BiocardiaInc's financial success or failures. It also enables traders to predict the movement of BiocardiaInc Stock. The fundamental analysis module provides a way to measure BiocardiaInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BiocardiaInc stock.
| Last Reported | Projected for Next Year | ||
| Market Cap | 14.1 M | 13.4 M |
BiocardiaInc | Market Capitalization |
BiocardiaInc Company Market Capitalization Analysis
BiocardiaInc's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current BiocardiaInc Market Capitalization | 10.13 M |
Most of BiocardiaInc's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BiocardiaInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
BiocardiaInc Market Capitalization Driver Correlations
Understanding the fundamental principles of building solid financial models for BiocardiaInc is extremely important. It helps to project a fair market value of BiocardiaInc Stock properly, considering its historical fundamentals such as Market Capitalization. Since BiocardiaInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BiocardiaInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BiocardiaInc's interrelated accounts and indicators.
Click cells to compare fundamentals
BiocardiaInc Market Capitalization Historical Pattern
Today, most investors in BiocardiaInc Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BiocardiaInc's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's market capitalization growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of BiocardiaInc market capitalization as a starting point in their analysis.
BiocardiaInc Market Capitalization |
| Timeline |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
BiocardiaInc Long Term Debt To Capitalization
Long Term Debt To Capitalization |
|
Based on the recorded statements, the market capitalization of BiocardiaInc is about 10.13 M. This is 99.92% lower than that of the Biotechnology sector and 99.79% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.95% higher than that of the company.
BiocardiaInc Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BiocardiaInc's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BiocardiaInc could also be used in its relative valuation, which is a method of valuing BiocardiaInc by comparing valuation metrics of similar companies.BiocardiaInc is currently under evaluation in market capitalization category among related companies.
BiocardiaInc Current Valuation Drivers
We derive many important indicators used in calculating different scores of BiocardiaInc from analyzing BiocardiaInc's financial statements. These drivers represent accounts that assess BiocardiaInc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BiocardiaInc's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 20.8M | 35.0M | 32.8M | 37.0M | 14.1M | 13.4M | |
| Enterprise Value | 16.3M | 14.2M | 21.8M | 31.3M | 14.3M | 13.6M |
BiocardiaInc Fundamentals
| Return On Equity | -7.04 | ||||
| Return On Asset | -1.14 | ||||
| Operating Margin | (160.31) % | ||||
| Current Valuation | 10.05 M | ||||
| Shares Outstanding | 26.87 M | ||||
| Shares Owned By Insiders | 33.84 % | ||||
| Shares Owned By Institutions | 7.71 % | ||||
| Number Of Shares Shorted | 535.91 K | ||||
| Price To Earning | (11.00) X | ||||
| Price To Book | 10.67 X | ||||
| Price To Sales | 21.85 X | ||||
| Revenue | 477 K | ||||
| Gross Profit | (7.48 M) | ||||
| EBITDA | (11.23 M) | ||||
| Net Income | (11.57 M) | ||||
| Cash And Equivalents | 8.61 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 1.31 M | ||||
| Debt To Equity | 0.26 % | ||||
| Current Ratio | 3.00 X | ||||
| Book Value Per Share | (0.07) X | ||||
| Cash Flow From Operations | (9.97 M) | ||||
| Short Ratio | 0.83 X | ||||
| Earnings Per Share | (0.55) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 16 | ||||
| Beta | 1.49 | ||||
| Market Capitalization | 10.13 M | ||||
| Total Asset | 2.99 M | ||||
| Retained Earnings | (152.18 M) | ||||
| Working Capital | (2.15 M) | ||||
| Current Asset | 19.48 M | ||||
| Current Liabilities | 330 K | ||||
| Net Asset | 2.99 M |
About BiocardiaInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BiocardiaInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiocardiaInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BiocardiaInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with BiocardiaInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiocardiaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiocardiaInc will appreciate offsetting losses from the drop in the long position's value.Moving against BiocardiaInc Stock
| 0.51 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.47 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to BiocardiaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiocardiaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiocardiaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BiocardiaInc to buy it.
The correlation of BiocardiaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiocardiaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BiocardiaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BiocardiaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out BiocardiaInc Piotroski F Score and BiocardiaInc Altman Z Score analysis. For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.Note that the BiocardiaInc information on this page should be used as a complementary analysis to other BiocardiaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for BiocardiaInc Stock analysis
When running BiocardiaInc's price analysis, check to measure BiocardiaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiocardiaInc is operating at the current time. Most of BiocardiaInc's value examination focuses on studying past and present price action to predict the probability of BiocardiaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiocardiaInc's price. Additionally, you may evaluate how the addition of BiocardiaInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is BiocardiaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BiocardiaInc. If investors know BiocardiaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BiocardiaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share 0.023 | Quarterly Revenue Growth (0.88) | Return On Assets (1.14) | Return On Equity (7.04) |
The market value of BiocardiaInc is measured differently than its book value, which is the value of BiocardiaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BiocardiaInc's value that differs from its market value or its book value, called intrinsic value, which is BiocardiaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BiocardiaInc's market value can be influenced by many factors that don't directly affect BiocardiaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BiocardiaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BiocardiaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BiocardiaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.